Evidence map›Paper›PMID 33845856›Full record

Trial reportTrials2021

The Early Youth Engagement in first episode psychosis (EYE-2) study: pragmatic cluster randomised controlled trial of implementation, effectiveness and cost-effectiveness of a team-based motivational engagement intervention to improve engagement.

Kathryn Greenwood, Rebecca Webb, Jenny Gu, David Fowler, Richard de Visser, Stephen Bremner, Iga Abramowicz, Nicky Perry, Stuart Clark, Anastacia O'Donnell and 21 more

Open access · goldAbstract readRandomized Controlled TrialPragmatic Clinical Trial
In one paragraph

Trial report in Trials, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.4field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 11 citations in OpenAlex.

  1. The impact of Patient and Public Involvement in the SlowMo study: Reflections on peer innovation.Health expectations : an international journal of public participation in health care and health policy · 2022
    Trial
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

31 authors at 16 institutions in 1 country.

Kathryn GreenwoodR&D, Sussex Partnership NHS Foundation Trust, Hove, UK. k.e.greenwood@sussex.ac.uk.ORCID http://orcid.org/0000-0001-7899-8980
Rebecca WebbSchool of Psychology, University of Sussex, Falmer, UK.
Jenny GuSchool of Psychology, University of Sussex, Falmer, UK.
David FowlerR&D, Sussex Partnership NHS Foundation Trust, Hove, UK.
Richard de VisserSchool of Psychology, University of Sussex, Falmer, UK.
Stephen BremnerBrighton and Sussex Medical School, University of Sussex, Falmer, UK.
Iga AbramowiczBrighton and Sussex Medical School, University of Sussex, Falmer, UK.
Nicky PerryBrighton and Sussex University Hospitals NHS Trust, Brighton, UK.
Stuart ClarkSussex Partnership NHS Foundation Trust, Hove, UK.
Anastacia O'DonnellSussex Partnership NHS Foundation Trust, Hove, UK.
Dan CharltonSussex Partnership NHS Foundation Trust, Hove, UK.
Rebecca JarvisSussex Partnership NHS Foundation Trust, Hove, UK.
Philippa GaretyKing's College London, Institute of Psychiatry Psychology and Neuroscience, London, UK.
Sunil NandhaSouth London and Maudsley NHS Foundation Trust, London, UK.
Belinda LennoxDepartment of Psychiatry, University of Oxford, Oxford, UK.
Louise JohnsDepartment of Psychiatry, University of Oxford, Oxford, UK.
Shanaya RathodSouthern Health NHS Foundation Trust, Southampton, UK.
Peter PhiriSouthern Health NHS Foundation Trust, Southampton, UK.
Paul FrenchPennine Care NHS Foundation Trust, Ashton-under-Lyne, UK.
Heather LawGreater Manchester Mental Health NHS Foundation Trust, Greater Manchester, UK.
Jo HodgekinsUniversity of East Anglia, Norwich, UK.
Michelle PainterCambridge and Peterborough NHS Foundation Trust, Cambridge, UK.
Cate TreiseCambridge and Peterborough NHS Foundation Trust, Cambridge, UK.
James PlaistowNorfolk and Suffolk NHS Foundation Trust, Norwich, UK.
Francis IrwinNorfolk and Suffolk NHS Foundation Trust, Norwich, UK.
Rose ThompsonMcPin Foundation, London, UK.
Tanya MackayMcPin Foundation, London, UK.
Carl R MayFaculty of Public Health and Policy, London School of Hygiene and Tropical Medicine, London, UK.
Andy HealeyKing's College London, Institute of Psychiatry Psychology and Neuroscience, London, UK.
Richard HooperInstitute of Population Health Sciences, Queen Mary University of London, London, UK.
Emmanuelle PetersKing's College London, Institute of Psychiatry Psychology and Neuroscience, London, UK.
Sussex Partnership NHS Foundation Trust · GBUniversity of Sussex · GBKing's College London · GBBrighton and Sussex Medical School · GBCambridgeshire and Peterborough NHS Foundation Trust · GBMcPin Foundation · GBNorfolk and Suffolk NHS Foundation Trust · GBOxford Health NHS Foundation Trust · GBSouthern Health NHS Foundation Trust · GBUniversity of East Anglia · GBGreater Manchester Mental Health NHS Foundation Trust · GBLondon School of Hygiene & Tropical Medicine · GBManchester Metropolitan University · GBQueen Mary University of London · GBSouth London and Maudsley NHS Foundation Trust · GBUniversity Hospitals Sussex NHS Foundation Trust · GB

Funding

Health Services and Delivery Research Programme 16/31/87
6 · The paper itself

Abstract

backgroundEarly Intervention in Psychosis (EIP) services improve health outcomes for young people with psychosis in the medium-long term, but 25% of young people disengage in the first 12 months with costs to their mental health, families, society and the NHS. This study will evaluate the effectiveness, cost-effectiveness and implementation of a team-based motivational Early Youth Engagement (EYE-2) intervention.

methodThe study design is a cluster randomised controlled trial (RCT) with economic evaluation, comparing the EYE-2 intervention + standardised EIP service to standardised EIP service alone, with randomisation at the team level. A process evaluation will evaluate the delivery of the intervention qualitatively and quantitatively across contexts. The setting is 20 EIP teams in 5 sites: Manchester, South London, East Anglia, Thames Valley and Hampshire. Participants are young people (14-35 years) with first episode psychosis, and EIP staff. The intervention is the team-based motivational engagement (EYE-2) intervention, delivered alongside standardised EIP services, and supported by additional training, website, booklets and social groups. The comparator is the standardised EIP service. Both interventions are delivered by EIP clinicians. The primary outcome is time to disengagement (time in days from date of allocation to care coordinator to date of last contact following refusal to engage with EIP service, or lack of response to EIP contact for a consecutive 3-month period). Secondary outcomes include mental and physical health, deaths, social and occupational function, recovery, satisfaction and service use at 6, 12, 18 and 24 months. A 12-month within-trial economic evaluation will investigate cost-effectiveness from a societal perspective and from an NHS perspective. DISCUSSION: The trial will provide the first test of an engagement intervention in standardised care, with the potential for significant impact on the mental health and wellbeing of young people and their families, and economic benefits for services. The intervention will be highly scalable, supported by the toolkit including manuals, commissioning guide, training and resources, adapted to meet the needs of the diverse EIP population, and based on an in-depth process evaluation.

trial registrationISRCTN 51629746 prospectively registered 7th May 2019. Date assigned 10th May 2019.

Indexed as

Psychotic DisordersAdolescentCost-Benefit AnalysisHumansLondonMental HealthMotivationEarly interventionEconomic evaluationEngagementInterventionProcess evaluationPsychosisRCT

Identifiers

PMID33845856
PMCPMC8042707
OpenAlexW3156120438

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.